BR9707161A - Preparação de um analgésico não-esteróide com efeito antipirético e anti-inflamatório e processo para produção da mesma - Google Patents

Preparação de um analgésico não-esteróide com efeito antipirético e anti-inflamatório e processo para produção da mesma

Info

Publication number
BR9707161A
BR9707161A BR9707161A BR9707161A BR9707161A BR 9707161 A BR9707161 A BR 9707161A BR 9707161 A BR9707161 A BR 9707161A BR 9707161 A BR9707161 A BR 9707161A BR 9707161 A BR9707161 A BR 9707161A
Authority
BR
Brazil
Prior art keywords
antipyretic
producing
preparation
weight
inflammatory effect
Prior art date
Application number
BR9707161A
Other languages
English (en)
Inventor
Jorg Breitenbach
Joerg Rosenberg
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of BR9707161A publication Critical patent/BR9707161A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BR9707161A 1996-01-23 1997-01-17 Preparação de um analgésico não-esteróide com efeito antipirético e anti-inflamatório e processo para produção da mesma BR9707161A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19602206A DE19602206A1 (de) 1996-01-23 1996-01-23 Zubereitungen nichtsteroidaler Analgetika
PCT/EP1997/000185 WO1997026866A2 (de) 1996-01-23 1997-01-17 Zubereitungen nichtsteroidaler analgetika

Publications (1)

Publication Number Publication Date
BR9707161A true BR9707161A (pt) 1999-05-18

Family

ID=7783389

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9707161A BR9707161A (pt) 1996-01-23 1997-01-17 Preparação de um analgésico não-esteróide com efeito antipirético e anti-inflamatório e processo para produção da mesma

Country Status (16)

Country Link
US (1) US6251434B1 (pt)
EP (1) EP0876141B1 (pt)
JP (1) JP4192256B2 (pt)
CN (1) CN1209741A (pt)
AT (1) ATE204749T1 (pt)
AU (1) AU711852B2 (pt)
BR (1) BR9707161A (pt)
DE (2) DE19602206A1 (pt)
DK (1) DK0876141T3 (pt)
ES (1) ES2162237T3 (pt)
GR (1) GR3036716T3 (pt)
MX (1) MX9805147A (pt)
PT (1) PT876141E (pt)
TW (1) TW394685B (pt)
WO (1) WO1997026866A2 (pt)
ZA (1) ZA97515B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19733505A1 (de) 1997-08-01 1999-02-04 Knoll Ag Schnell wirksames Analgeticum
US7364752B1 (en) 1999-11-12 2008-04-29 Abbott Laboratories Solid dispersion pharamaceutical formulations
JP5767429B2 (ja) * 1999-11-12 2015-08-19 アッヴィ・インコーポレイテッド 固体分散剤中の結晶化阻害剤
DE10026698A1 (de) * 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
DE10313446A1 (de) * 2003-03-26 2004-10-14 Krewel Meuselbach Gmbh Phenazon-haltiges Migränemedikament
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
FR2865648B1 (fr) * 2004-02-03 2006-06-30 Philippe Perovitch Procede de diffusion de molecules insolubles en milieu aqueux et composition mettant en oeuvre ce procede
EP2140861A1 (en) * 2008-06-30 2010-01-06 Abbott GmbH & Co. KG Pharmaceutical dosage form comprising polymeric carrier composition

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3612212A1 (de) * 1986-04-11 1987-10-15 Basf Ag Verfahren zur herstellung von festen pharmazeutischen formen
EP0607467B1 (de) 1992-12-01 1999-06-02 Spirig Ag Pharmazeutische Präparate S(+)-Ibuprofen enthaltende Arzneimittel
DE19509807A1 (de) * 1995-03-21 1996-09-26 Basf Ag Verfahren zur Herstellung von Wirkstoffzubereitungen in Form einer festen Lösung des Wirkstoffs in einer Polymermatrix sowie mit diesem Verfahren hergestellte Wirkstoffzubereitungen
DE4418837A1 (de) * 1994-05-30 1995-12-07 Bayer Ag Thermisches Granulierverfahren
DE19509805A1 (de) * 1995-03-21 1996-09-26 Basf Ag Transparente, schnell freisetzende Zubereitungen von nichtsteroidalen Analgetica
DE19509806A1 (de) * 1995-03-21 1996-09-26 Basf Ag Lagerstabile Arzneiformen

Also Published As

Publication number Publication date
CN1209741A (zh) 1999-03-03
TW394685B (en) 2000-06-21
EP0876141B1 (de) 2001-08-29
ES2162237T3 (es) 2001-12-16
ZA97515B (en) 1998-07-22
WO1997026866A2 (de) 1997-07-31
ATE204749T1 (de) 2001-09-15
DE59704445D1 (de) 2001-10-04
AU711852B2 (en) 1999-10-21
PT876141E (pt) 2002-02-28
WO1997026866A3 (de) 1997-09-18
DE19602206A1 (de) 1997-07-24
MX9805147A (es) 1998-10-31
AU1541697A (en) 1997-08-20
JP2000503971A (ja) 2000-04-04
GR3036716T3 (en) 2001-12-31
EP0876141A2 (de) 1998-11-11
JP4192256B2 (ja) 2008-12-10
DK0876141T3 (da) 2001-10-08
US6251434B1 (en) 2001-06-26

Similar Documents

Publication Publication Date Title
DE59202537D1 (de) Feste pharmazeutische Retardform.
CA2239174A1 (en) Novel compounds with analgesic effect
ATE220541T1 (de) Feste wirkstoff-zubereitungen
HUP9902612A2 (hu) Interleukin-I inhibitort és kontrollált felszabadulású polimert tartalmazó készítmények
BR9406363A (pt) Composiçao farmacêutica processo para a preparaçao da mesma uso da mesma e processo para o tratamento de doenças relacionadas com o ácido gástrico
RO116342B1 (ro) Compoziţie farmaceutică lichidă, orală
MY119403A (en) Novel compounds with analgesic effect.
EP0382066A3 (de) Verwendung von Dihydroliponsäure als Analgetikum, Antiphlogistikum und/oder Zytoprotektivum
HUP9801152A2 (hu) Nem-szteroid analgetikumok átlátszó, gyors hatóanyagkibocsátású készítményei
WO1999008657A3 (en) Self-binding shearform compositions
BR9707161A (pt) Preparação de um analgésico não-esteróide com efeito antipirético e anti-inflamatório e processo para produção da mesma
FI963394A0 (fi) Yskää vastustava koostumus, joka sisältää yskää vastustavaa ainetta ja bentsydamiinia
SE9504662D0 (sv) New compounds
SE9604752D0 (sv) Formulation and use
AU570937B2 (en) Synergistic composition of hydroxyzine and salts thereof with nsaids
CA2243522A1 (en) Preparations of non-steroidal analgesics
IT7926507A0 (it) Derivati ad attivita' antidolorifica, antipiretica,antinfiammatoria, procedimento per la loro preparazione e composizioni farmaceutiche con tenenti detti derivati.
IT9022371A0 (it) Derivati dell'1-arilsolfonil 2-pirrolidone, loro procedimento di preparazione e i nuovi intermedi cosi' ottenuti, il loro impiego come farmaci e le composizioni farmaceutiche che li contengono.
IT8320325A0 (it) Composto ad attivita'analgesica, antipiretica, antiinfiammatoria e muscolorilassante, procedimento per la sua preparazione e relative composizioni farmaceutiche.
IT8221907A0 (it) Nuovo composto ad attivita'analgesica, antipiretica, antiinfiammatoria e muscolorilassante, procedimento per la sua preparazione e relative composizioni farmaceutiche.
IT8921787A0 (it) Nuovo derivato antiinfiammatorio analgesico e antipiretico, sua preparazione e composizioni farmaceutiche.
IT7925792A0 (it) Composto ad attivita'antiinfiammatoria, analgesica e antipiretica, e formulazioni farmaceutiche relative.
IT8521801A0 (it) 1,4-diamino-butano, suoi derivati mano-e diacilati, che posseggono attivita' analgesica, antiinfiammatoria ed antipiretica; metodi di preparazione e forme farmaceutiche che li contengono come principi attivi.
YU48054B (sh) Postupak za proizvodnju farmaceutskog preparata

Legal Events

Date Code Title Description
FB36 Technical and formal requirements: requirement - article 36 of industrial property law
B25A Requested transfer of rights approved

Free format text: ABBOTT GMBH & CO. KG (DE)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B24C Patent annual fee: request for for restoration

Free format text: REFERENTE A 13A E 14A ANUIDADES

B24H Lapse because of non-payment of annual fees (definitively: art 78 iv lpi)
B24F Patent annual fee: publication cancelled

Free format text: ANULADA A PUBLICACAO CODIGO 24.8 NA RPI NO 2259 DE 22/04/2014 POR TER SIDO INDEVIDA.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE AS 13A E 14A ANUIDADES.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2606 DE 15-12-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.